Regeneron Pharmaceuticals, Inc.
REGN
Below: live stock price for Regeneron Pharmaceuticals, Inc. (REGN), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Regeneron Pharmaceuticals, Inc. (REGN) trades at 676.69 USD on investpig.
- Prev close
- $678.94
- Volume (24h)
- $438.77M
- Market cap
- $70.94B
- Currency
- USD
Score
50/ 100 · Mixed
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 670.7983 -0.87%
- +20 bars
- 662.7532 -2.06%
- +60 bars
- 659.6668 -2.52%
- +120 bars
- 659.5539 -2.53%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0566 USD.
Interpretation
Price sits in the middle of the recent range, trend is sloping downward.
Descriptive observation — not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
- ResistanceFib +161.8% extension1,051.48 USD+55.39% from current
- ResistanceFib +100% extension942.9 USD+39.34% from current
- ResistanceFib +61.8% extension875.7864 USD+29.42% from current
- ResistanceFib +27.2% extension814.9977 USD+20.44% from current
- ResistanceFib 23.6% retracement725.7472 USD+7.25% from current
- ResistanceFib 38.2% retracement700.0964 USD+3.46% from current
- ResistanceFib 50% midpoint679.365 USD+0.40% from current
- Current676.69 USD
- SupportFib 61.8% retracement658.6336 USD-2.67% from current
- SupportFib 78.6% retracement629.1177 USD-7.03% from current
- SupportFib −27.2% extension543.7323 USD-19.65% from current
- SupportFib −61.8% extension482.9436 USD-28.63% from current
- SupportFib −100% extension415.83 USD-38.55% from current
Recent news
- What Comes After Merck’s Keytruda? The Race for the Next Standard Cancer Treatment.Barrons.com3h ago
- Regeneron Pharmaceuticals (REGN) Rebounds As Undervalued View Holds, Is The Upside Already Priced In?Simply Wall St.2d ago
- The weight-loss drugs boom is creating both winners and wipeouts: One Big Investment IdeaYahoo Finance2d ago
- 3 High-Yield Dividend Stocks to Buy and HoldMotley Fool3d ago
- Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology StocksStockStory3d ago
- Merck Snags A First-Of-Its-Kind Approval, And Shares JumpInvestor's Business Daily3d ago
- Merck Stock Rises After U.S. Approval for Powerful Cholesterol-Cutting PillBarrons.com3d ago
- Collect 9.8% On VRTX Stock Now, And Still Keep 15% Of UpsideTrefis3d ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,473 USD-4.30%
- 7203.TToyota Motor Corporation2,899.5 USD-0.33%
- 9984.TSoftBank Group Corp.5,424 USD-9.01%
- 6758.TSony Group Corporation3,470 USD+0.93%
- 6861.TKeyence Corporation70,880 USD-4.28%
- NVDANVIDIA Corporation202.81 USD-2.21%
- AAPLApple Inc.333.74 USD+0.14%
- 0700.HKTencent Holdings Limited477.8 USD+3.51%
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.